Current Smoking Is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis.

Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
01 Dec 2019
Historique:
pubmed: 4 12 2019
medline: 4 12 2019
entrez: 3 12 2019
Statut: aheadofprint

Résumé

The effect of smoking in psoriatic arthritis (PsA) is under debate. Our aim was to test whether smoking is increased in axial PsA (axPsA). Included in the analysis were 1535 patients from PsArt-ID (PsA-International Database). The effect of smoking on axPsA (compared to other PsA phenotypes) and radiographic sacroiliitis were investigated. Current smoking was more common in axPsA (28.6% vs 18.9%, p < 0.001). It also was found as an independent predictor of axPsA (OR 1.4) and radiographic sacroiliitis (OR 6.6). Current smoking is significantly associated with both axPsA and radiographic sacroiliitis in patients with PsA.

Identifiants

DOI: 10.3899/jrheum.190722 PMID: 31787608
pubmed: 31787608
pii: jrheum.190722
doi: 10.3899/jrheum.190722
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Auteurs

Dilek Solmaz (D)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0002-9035-689X

Umut Kalyoncu (U)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-7129-2109

Ilaria Tinazzi (I)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.

Sibel Bakirci (S)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0002-2745-7700

Ozun Bayindir (O)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-9822-7948

Atalay Dogru (A)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0002-9797-1182

Ediz Dalkilic (E)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-8645-2670

Gezmis Kimyon (G)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0003-3775-639X

Cem Ozisler (C)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-7475-3927

Gozde Yildirim Cetin (GY)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-9680-7535

Levent Kilic (L)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.

Ahmet Omma (A)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0003-2582-7445

Meryem Can (M)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0002-9927-3644

Sema Yilmaz (S)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0003-4277-3880

Abdulsamet Erden (A)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0002-8084-2018

Sibel Zehra Aydin (SZ)

From the University of Ottawa Faculty of Medicine, Rheumatology, and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital, Ankara, Turkey; Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy; Ege University, Department of Internal Medicine, Division of Rheumatology, Izmir, Turkey; Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology, Isparta, Turkey; Uludag University, Department of Internal Medicine, Division of Rheumatology, Bursa, Turkey; Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology, Hatay, Turkey; Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology, Kahramanmaras, Turkey; Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey; Marmara University, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey; Selcuk University, Department of Internal Medicine, Division of Rheumatology, Konya, Turkey. D. Solmaz had funding from Union ChimiqueBelge (UCB) for an axial spondyloarthritis fellowship. S. Bakirci had funding from the Turkish Society for Rheumatology (TRD). S.Z. Aydin received honoraria from Abbvie, Celgene, UCB, Novartis, Jannsen, and Sanofi. D. Solmaz, MD, University of Ottawa Faculty of Medicine, Rheumatology; U. Kalyoncu, MD, Associate Professor, Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology; I. Tinazzi, MD, Unit of Rheumatology, Sacro Cuore-Don Calabria Hospital; S. Bakirci, MD, University of Ottawa Faculty of Medicine, Rheumatology; O. Bayindir, MD, Ege University, Department of Internal Medicine, Division of Rheumatology; A. Dogru, MD, Suleyman Demirel University, Department of Internal Medicine, Division of Rheumatology; E. Dalkilic, MD, Associate Professor, Uludag University, Department of Internal Medicine, Division of Rheumatology; G. Kimyon, MD, Mustafa Kemal University, Department of Internal Medicine, Division of Rheumatology; C. Ozisler, MD, Diskapi Yildirim Beyazit Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; G.Y. Cetin, MD, Associate Professor, Kahramanmaras Sutcu Imam University, Department of Internal Medicine, Division of Rheumatology; L. Kilic, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology, Hacettepe University Hospital; A. Omma, MD, Ankara Numune Education and Research Hospital, Department of Internal Medicine, Division of Rheumatology; M. Can, MD, Associate Professor, Marmara University, Department of Internal Medicine, Division of Rheumatology; S. Yilmaz, MD, Professor, Selcuk University, Department of Internal Medicine, Division of Rheumatology; A. Erden, MD, Hacettepe University, Department of Internal Medicine, Division of Rheumatology; S.Z. Aydin, MD, Associate Professor, University of Ottawa Faculty of Medicine, Ottawa Hospital Research Institute. Address correspondence to Dr. S.Z. Aydin, 1967 Riverside Drive, Ottawa, Ontario K1H 7W9, Canada. E-mail: saydin@toh.ca. Accepted for publication November 13, 2019.
ORCID: 0000-0001-8792-4449

Classifications MeSH